45 related articles for article (PubMed ID: 27253753)
1. Cancer-associated variants and a common polymorphism of MUTYH exhibit reduced repair of oxidative DNA damage using a GFP-based assay in mammalian cells.
Raetz AG; Xie Y; Kundu S; Brinkmeyer MK; Chang C; David SS
Carcinogenesis; 2012 Nov; 33(11):2301-9. PubMed ID: 22926731
[TBL] [Abstract][Full Text] [Related]
2. Incident Cancer Risk and Signatures Among Older MUTYH Carriers: Analysis of Population-Based and Genomic Cohorts.
Downie JM; Riaz M; Xie J; Lee M; Chan AT; Gibbs P; Orchard SG; Mahady SE; Sebra RP; Murray AM; Macrae F; Schadt E; Woods RL; McNeil JJ; Lacaze P; Gala M
Cancer Prev Res (Phila); 2022 Aug; 15(8):509-519. PubMed ID: 35609203
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress accelerates intestinal tumorigenesis by enhancing 8-oxoguanine-mediated mutagenesis in MUTYH-deficient mice.
Ohno M; Takano N; Hidaka K; Sasaki F; Yamauchi K; Aoki Y; Nohmi T; Nakabeppu Y; Nakatsu Y; Tsuzuki T
Genome Res; 2024 Feb; 34(1):47-56. PubMed ID: 38290979
[TBL] [Abstract][Full Text] [Related]
4. Cellular Repair of Synthetic Analogs of Oxidative DNA Damage Reveals a Key Structure-Activity Relationship of the Cancer-Associated MUTYH DNA Repair Glycosylase.
Conlon SG; Khuu C; Trasviña-Arenas CH; Xia T; Hamm ML; Raetz AG; David SS
ACS Cent Sci; 2024 Feb; 10(2):291-301. PubMed ID: 38435525
[TBL] [Abstract][Full Text] [Related]
5. Molecular classification of prostate adenocarcinoma by the integrated somatic mutation profiles and molecular network.
Yang L; Wang S; Zhou M; Chen X; Jiang W; Zuo Y; Lv Y
Sci Rep; 2017 Apr; 7(1):738. PubMed ID: 28389666
[TBL] [Abstract][Full Text] [Related]
6. Whole-genome landscape of pancreatic neuroendocrine tumours.
Scarpa A; Chang DK; Nones K; Corbo V; Patch AM; Bailey P; Lawlor RT; Johns AL; Miller DK; Mafficini A; Rusev B; Scardoni M; Antonello D; Barbi S; Sikora KO; Cingarlini S; Vicentini C; McKay S; Quinn MC; Bruxner TJ; Christ AN; Harliwong I; Idrisoglu S; McLean S; Nourse C; Nourbakhsh E; Wilson PJ; Anderson MJ; Fink JL; Newell F; Waddell N; Holmes O; Kazakoff SH; Leonard C; Wood S; Xu Q; Nagaraj SH; Amato E; Dalai I; Bersani S; Cataldo I; Dei Tos AP; Capelli P; Davì MV; Landoni L; Malpaga A; Miotto M; Whitehall VL; Leggett BA; Harris JL; Harris J; Jones MD; Humphris J; Chantrill LA; Chin V; Nagrial AM; Pajic M; Scarlett CJ; Pinho A; Rooman I; Toon C; Wu J; Pinese M; Cowley M; Barbour A; Mawson A; Humphrey ES; Colvin EK; Chou A; Lovell JA; Jamieson NB; Duthie F; Gingras MC; Fisher WE; Dagg RA; Lau LM; Lee M; Pickett HA; Reddel RR; Samra JS; Kench JG; Merrett ND; Epari K; Nguyen NQ; Zeps N; Falconi M; Simbolo M; Butturini G; Van Buren G; Partelli S; Fassan M; ; Khanna KK; Gill AJ; Wheeler DA; Gibbs RA; Musgrove EA; Bassi C; Tortora G; Pederzoli P; Pearson JV; Waddell N; Biankin AV; Grimmond SM
Nature; 2017 Mar; 543(7643):65-71. PubMed ID: 28199314
[TBL] [Abstract][Full Text] [Related]
7. Multi-Dimensional Scaling Analysis of Key Regulatory Genes in Prostate Cancer Using the TCGA Database.
Boldrini L; Faviana P; Galli L; Paolieri F; Erba PA; Bardi M
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573332
[TBL] [Abstract][Full Text] [Related]
8. A maternal germline mutator phenotype in a family affected by heritable colorectal cancer.
Young CL; Beichman AC; Mas-Ponte D; Hemker SL; Zhu L; Kitzman JO; Shirts B; Harris K
medRxiv; 2023 Dec; ():. PubMed ID: 38196581
[TBL] [Abstract][Full Text] [Related]
9. Genomic Frequencies of Dynamic DNA Sequences and Mammalian Lifespan.
Martella M; Carlesso N; Waller ZAE; Marcucci G; Pichiorri F; Smith SS
Cancer Genomics Proteomics; 2024; 21(3):238-251. PubMed ID: 38670588
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic/Likely Pathogenic Somatic CDK12 Mutations in Black Men With Prostate Cancer.
Sartor O; Jang A; Ledet E
Oncologist; 2023 Nov; 28(11):e1127-e1128. PubMed ID: 37589230
[TBL] [Abstract][Full Text] [Related]
11. In Reply to "Pathogenic/Likely Pathogenic Somatic CDK12 Mutations in Black Men With Prostate Cancer".
Valle LF; Nickols NG; Yamoah K; Garraway IP; Maxwell KN; Lynch JA
Oncologist; 2023 Nov; 28(11):e1129-e1130. PubMed ID: 37706534
[TBL] [Abstract][Full Text] [Related]
12. New insights into APOBEC-mediated mutagenesis in prostate cancer.
Masone MC
Nat Rev Urol; 2023 Sep; 20(9):519. PubMed ID: 37553529
[No Abstract] [Full Text] [Related]
13. Letter to the editor: Aggressive variant prostate cancer: An exemplary case study and comprehensive literature survey.
Ke HW; Zhang WY; Xu KX
World J Clin Cases; 2023 Dec; 11(35):8431-8433. PubMed ID: 38130605
[TBL] [Abstract][Full Text] [Related]
14. Aggressive variant prostate cancer: A case report and literature review.
Weng XT; Lin WL; Pan QM; Chen TF; Li SY; Gu CM
World J Clin Cases; 2023 Sep; 11(26):6213-6222. PubMed ID: 37731555
[TBL] [Abstract][Full Text] [Related]
15. Towards a comprehensive view of 8-oxo-7,8-dihydro-2'-deoxyguanosine: Highlighting the intertwined roles of DNA damage and epigenetics in genomic instability.
Gorini F; Scala G; Cooke MS; Majello B; Amente S
DNA Repair (Amst); 2021 Jan; 97():103027. PubMed ID: 33285475
[TBL] [Abstract][Full Text] [Related]
16. POLQ Overexpression Is Associated with an Increased Somatic Mutation Load and PLK4 Overexpression in Lung Adenocarcinoma.
Shinmura K; Kato H; Kawanishi Y; Yoshimura K; Tsuchiya K; Takahara Y; Hosokawa S; Kawase A; Funai K; Sugimura H
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31137743
[TBL] [Abstract][Full Text] [Related]
17. The Pivotal Role of DNA Repair in Infection Mediated-Inflammation and Cancer.
Sahan AZ; Hazra TK; Das S
Front Microbiol; 2018; 9():663. PubMed ID: 29696001
[TBL] [Abstract][Full Text] [Related]
18. Mutation Spectrum Induced by 8-Bromoguanine, a Base Damaged by Reactive Brominating Species, in Human Cells.
Shinmura K; Kato H; Goto M; Tao H; Inoue Y; Nakamura S; Yoshida H; Tsuzaki E; Sugimura H
Oxid Med Cell Longev; 2017; 2017():7308501. PubMed ID: 29098062
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of the DNA glycosylase gene MUTYH is associated with an increased number of somatic mutations via a reduction in the DNA repair capacity in prostate adenocarcinoma.
Shinmura K; Kato H; Kawanishi Y; Yoshimura K; Igarashi H; Goto M; Tao H; Inoue Y; Sugiyama T; Furuse H; Ozono S; Sugimura H
Mol Carcinog; 2017 Feb; 56(2):781-788. PubMed ID: 27253753
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
